Loading stock data…
Hims & Hers Health (HIMS)
$33.39-0.55 (-1.62%)
Market ClosedLast close Jun 29
Hims & Hers Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Hims & Hers Health, Inc. in the Healthcare sector is trading at $33.39 with a market capitalization of $7.2B. Wall Street consensus targets $27.32 (14 analysts), implying a -18.2% move over the next 12 months. The stock is currently 53% below its 52-week high of $70.43, remaining 1.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -18.2% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $608.10M↓ | $617.82M↑ | $598.98M↑ | $544.83M↓ | $586.01M |
| Gross Profit | $396.79M↓ | $444.44M↑ | $442.06M↑ | $416.20M↓ | $430.69M |
| Operating Income | -$78.32M↓ | $9.19M↓ | $11.81M↓ | $26.72M↓ | $57.90M |
| Net Income | -$92.11M↓ | $20.60M↑ | $15.77M↓ | $42.51M↓ | $49.48M |
Peer Comparison
JNJUNHPFE
Fundamentals
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and int...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.97%
Volume
Today's trading volume
13.93M
Recent News
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $33.39, indicating a -1.62% shift from the previous trading day.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
HIMS Stock Eyes Big Monthly Win: Novo Nordisk Calls Hims & Hers One Of Its Most ‘Voluminous’ Telehealth Partners
Hims had 2.6 million subscribers in Q1, up 9% year over year, with Q2 expected to show how much the Novo deal is helping demand.
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?
We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best weight loss drugs on this list. TheFly reported on June 17 that Barclays maintained its Overweight rating on HIMS while increasing its price target to $39.00 from $29.00. The […]
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $32.96, moving 1.73% from the previous trading session.